PROPANC BIOPHARMA, INC.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | — | — | — | $87.8K | $0 | $179 | $132 | — |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $82.0K | $362.8K | $621.9K | $113.7K | $1.2K | $41.7K | $10.8M | — |
| Property, Plant & Equipment | $10.8K | $12.5K | $3.5K | $0 | $538 | $4.6K | $6.7K | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $95.1K | $379.1K | $627.1K | $113.7K | $1.7K | $46.3K | $10.8M | — |
| Liabilities | ||||||||
| Accounts Payable | $483.5K | $370.1K | $236.5K | $350.0K | $272.6K | $192.5K | $27.7K | — |
| Total Current Liabilities | $5.5M | $2.9M | $3.7M | $1.5M | $794.2K | $584.2K | $306.8K | — |
| Long-Term Debt | $3.5M | $1.2M | — | — | — | — | — | — |
| Total Liabilities | $5.5M | $2.9M | $3.7M | $1.5M | $794.2K | $584.2K | $306.8K | — |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-38.2M | $-30.4M | $-21.0M | $-17.6M | — | — | — | — |
| Total Stockholders' Equity | $-5.4M | $-2.6M | $-3.1M | $-1.4M | $-792.5K | $-537.9K | $10.5M | $-186.9K |